Liquidia (LQDA) Change in Account Payables (2020 - 2026)
Liquidia (LQDA) posted quarterly Change in Account Payables of $562000.0 for Q1 2026, down 83.56% year-over-year from $3.4 million in Q1 2025, and up 128.62% quarter-over-quarter from -$2.0 million in Q4 2025.
Liquidia (LQDA) Change in Account Payables (2020 - 2026) Analysis & Trends
Liquidia's Change in Account Payables history runs 7 years deep, the most recent figure standing at $562000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 83.56% year-over-year to $562000.0; the TTM figure through Mar 2026 stood at -$5.4 million (down 200.07% YoY), while the FY2025 annual figure was -$2.6 million, down 211.29% from the prior year.
- Change in Account Payables for Q1 2026 stood at $562000.0, up from -$2.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.4 million in Q1 2025, with the low at -$6.0 million in Q3 2025.
- The 5-year median for Change in Account Payables is $303000.0 (2024), against an average of -$2294.1.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables sank 1857.95% in 2024, then soared 1028.05% in 2025.
- Liquidia's Change in Account Payables stood at $1.0 million in 2022, then plunged by 158.6% to -$596000.0 in 2023, then jumped by 528.19% to $2.6 million in 2024, then plunged by 176.96% to -$2.0 million in 2025, then soared by 128.62% to $562000.0 in 2026.
- Business Quant data shows LQDA's Change in Account Payables at $562000.0 in Q1 2026, -$2.0 million in Q4 2025, and -$6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Liquidia | 6.39 Bn | 6.10 Bn | 160.92 Mn | -1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.15 Mn |
| Jun 30, 2026 | -1.15 Mn |
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -1.96 Mn |
| Dec 31, 2025 | -1.96 Mn |
| Sep 30, 2025 | -5.99 Mn |
| Sep 30, 2025 | -5.99 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 303,000.00 |
| Mar 31, 2024 | 303,000.00 |